MIR-625 suppresses cell proliferation and migration by targeting HMGA1 in breast cancer

Biochemical and Biophysical Research Communications

Volumn 470, Issue 4, 2016, Pages 838-844

  Zhou, Wen Bin ^a   Zhong, Cai Neng ^a   Luo, Xun Peng ^a   Zhang, Ya Yuan ^a   Zhang, Gui Ying ^a   Zhou, Dong Xian ^a   Liu, Li Ping ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Breast cancer; HMGA1; Migration; MIR 625; Proliferation

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HIGH MOBILITY GROUP A PROTEIN; HIGH MOBILITY GROUP A1 PROTEIN; KI 67 ANTIGEN; MESSENGER RNA; MICRORNA; MICRORNA 625; PROGESTERONE RECEPTOR; TUMOR MARKER; UNCLASSIFIED DRUG; HIGH MOBILITY GROUP A1A PROTEIN; MIRN625 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER INHIBITION; CANCER PROGNOSIS; CANCER STAGING; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN TARGETING; TUMOR GROWTH; TUMOR VOLUME; UPREGULATION; ADOLESCENT; BREAST TUMOR; CELL MOTION; CHINA; EPIDEMIOLOGY; INCIDENCE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; RISK FACTOR; SURVIVAL RATE; TUMOR CELL CULTURE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; CHINA; FEMALE; HMGA1A PROTEIN; HUMANS; INCIDENCE; MICRORNAS; MIDDLE AGED; RISK FACTORS; SURVIVAL RATE; TUMOR CELLS, CULTURED; YOUNG ADULT;

EID: 84957431068     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.01.122     Document Type: Article

References (21)

1. L.A. Torre, F. Bray, R.L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal Global cancer statistics, 2012 CA Cancer J. Clin. 65 2015 87 108
2. R. Ha, D. Chow, and R. Wynn Global trend in breast cancer imaging research 1992-2012: bibliometric study AJR Am. J. Roentgenol. 202 2014 696 697
3. C. Allemani, H.K. Weir, H. Carreira, R. Harewood, D. Spika, X.S. Wang, F. Bannon, J.V. Ahn, C.J. Johnson, A. Bonaventure, R. Marcos-Gragera, C. Stiller, G. Azevedo e Silva, W.Q. Chen, O.J. Ogunbiyi, B. Rachet, M.J. Soeberg, H. You, T. Matsuda, M. Bielska-Lasota, H. Storm, T.C. Tucker, and M.P. Coleman Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2) Lancet 385 2015 977 1010
4. R.U. Takahashi, H. Miyazaki, F. Takeshita, Y. Yamamoto, K. Minoura, M. Ono, M. Kodaira, K. Tamura, M. Mori, and T. Ochiya Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1 Nat. Commun. 6 2015 7318
5. X. Wang, Y. Li, W. Qi, N. Zhang, M. Sun, Q. Huo, C. Cai, S. Lv, and Q. Yang MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells Oncotarget 6 2015 32737 32747
6. M. Wang, C. Li, H. Nie, X. Lv, Y. Qu, B. Yu, L. Su, J. Li, X. Chen, J. Ju, Y. Yu, M. Yan, Q. Gu, Z. Zhu, and B. Liu Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK FEBS Lett. 586 2012 2382 2388
7. X. Zhou, C.Z. Zhang, S.X. Lu, G.G. Chen, L.Z. Li, L.L. Liu, C. Yi, J. Fu, W. Hu, J.M. Wen, and J.P. Yun miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma Oncogene 34 2015 965 977
8. H. Zheng, R. Ma, Q. Wang, P. Zhang, D. Li, J. Wang, H. Li, H. Liu, and Z. Wang miR-625-3p promotes cell migration and invasion via inhibition of SCAI in colorectal carcinoma cells Oncotarget 6 2015 27805 27815
9. M.B. Kirschner, Y.Y. Cheng, B. Badrian, S.C. Kao, J. Creaney, J.J. Edelman, N.J. Armstrong, M.P. Vallely, A.W. Musk, B.W. Robinson, B.C. McCaughan, S. Klebe, S.E. Mutsaers, N. van Zandwijk, and G. Reid Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesothelioma J. Thorac. Oncol. 7 2012 1184 1191
10. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
11. L.L. Liu, S.X. Lu, M. Li, L.Z. Li, J. Fu, W. Hu, Y.Z. Yang, R.Z. Luo, C.Z. Zhang, and J.P. Yun FoxD3-regulated microRNA-137 suppresses tumour growth and metastasis in human hepatocellular carcinoma by targeting AKT2 Oncotarget 5 2014 5113 5124
12. Z.G. Zhang, W.X. Chen, Y.H. Wu, H.F. Liang, and B.X. Zhang MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1 Biochem. Biophys. Res. Commun. 454 2014 109 114
13. G.M. Pierantoni, A. Conte, C. Rinaldo, M. Tornincasa, R. Gerlini, A. Federico, D. Valente, E. Medico, and A. Fusco Deregulation of HMGA1 expression induces chromosome instability through regulation of spindle assembly checkpoint genes Oncotarget 6 2015 17342 17353
14. B. Gogoi, P. Chatterjee, S. Mukherjee, A.K. Buragohain, S. Bhattacharya, and S. Dasgupta A polyphenol rescues lipid induced insulin resistance in skeletal muscle cells and adipocytes Biochem. Biophys. Res. Commun. 452 2014 382 388
15. R. Lin, W. Shen, Y. Zhi, and Z. Zhou Prognostic value of miR-26a and HMGA1 in urothelial bladder cancer Biomed. Pharmacother. 68 2014 929 934
16. Z. Zhang, Q. Wang, F. Chen, and J. Liu Elevated expression of HMGA1 correlates with the malignant status and prognosis of non-small cell lung cancer Tumour Biol. 36 2015 1213 1219
17. R. Huang, D. Huang, W. Dai, and F. Yang Overexpression of HMGA1 correlates with the malignant status and prognosis of breast cancer Mol. Cell Biochem. 404 2015 251 257
18. F. Di Cello, J. Shin, K. Harbom, and C. Brayton Knockdown of HMGA1 inhibits human breast cancer cell growth and metastasis in immunodeficient mice Biochem. Biophys. Res. Commun. 434 2013 70 74
19. S. Pegoraro, G. Ros, Y. Ciani, R. Sgarra, S. Piazza, and G. Manfioletti A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness Oncotarget 6 2015 19087 19101
20. K. Liu, C. Zhang, T. Li, Y. Ding, T. Tu, F. Zhou, W. Qi, H. Chen, and X. Sun Let-7a inhibits growth and migration of breast cancer cells by targeting HMGA1 Int. J. Oncol. 46 2015 2526 2534
21. Y. Lin, H. Chen, Z. Hu, Y. Mao, X. Xu, Y. Zhu, J. Wu, S. Li, Q. Mao, X. Zheng, and L. Xie miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1 FEBS Lett. 587 2013 2467 2473